Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate

Seminars in Arthritis and Rheumatism

Volumn 16, Issue 3, 1987, Pages 186-195

  Carson, Craig W ^a   Cannon, Grant W ^a   Egger, Marlene J ^a   Ward, John R ^a   Clegg, Daniel O ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CEFAZOLIN; CHLORAMBUCIL; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; GENTAMICIN; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; NAPROXEN; PENICILLAMINE; PREDNISONE; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ADVERSE DRUG REACTION; CLINICAL ARTICLE; COUGHING; DRUG DOSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG THERAPY; DYSPNEA; FEVER; HUMAN; INTOXICATION; JOINT; LUNG TOXICITY; ORAL DRUG ADMINISTRATION; PNEUMONIA; RESPIRATORY SYSTEM; RHEUMATOID ARTHRITIS; THERAPY; THORAX PAIN;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LUNG DISEASES; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0023143528     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(87)90021-7     Document Type: Article

References (52)

1. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis
2. Efficacy of low-dose methotrexate in rheumatoid arthritis
3. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study
4. Low dose pulse methotrexate therapy in rheumatoid arthritis
5. Weekly intravenous methotrexate in the treatment of rheumatoid arthritis
6. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations
7. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature
8. Pancytopenia associated with low dose pulse methotrexate of rheumatoid arthritis
9. Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems
10. Pulmonary and hepatic complications of methotrexate therapy of psoriasis
11. Methotrexate-induced pneumonitis
12. Cooperative Study
13. Pulmonary disease complicating intermittent therapy with methotrexate
14. Methotrexate pneumonitis induced by intrathecal methotrexate therapy. A case report with pharmacokinetic data
15. Methotrexate-induced sudden fatal pulmonary reaction
16. Methotrexate therapy and pulmonary disease
17. Progressive interstitial lung disease from prolonged methotrexate therapy
18. Methotrexate-induced diffuse interstitial pulmonary fibrosis
19. Severe pneumonitis occurring during methotrexate therapy
20. Methotrexate therapy in polymyositis
21. Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis
22. Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis
23. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis
24. A long-term prospective study of methotrexate in rheumatoid arthritis
25. Comparison of auranofin, gold sodium thiomalate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial
26. Gold therapy in rheumatoid arthritis Final report of a multicenter controlled clinical trial
27. Low-dose, d-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial
28. Azathioprine versus d-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold
29. Hydroxychloroquine sulfate in rheumatoid arthritis. A six month double-blind trial
30. Azathioprine in rheumatoid arthritis: A double-blind study comparing full dose and half dose
31. Controlled trial of cyclophosphamide in rheumatoid arthritis
32. Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis
33. Chlorambucil therapy in rheumatoid arthritis Clinical experience in 28 patients and literature review
34. Adverse reactions to nitrofurantoin Analysis of 921 reports
35. Pleuropneumonic reactions to nitrofurantoin
36. Nitrofurantoin pulmonary complications
37. The histopathology of acute nitrofurantoin-associated pneumonitis
38. Nitrofurantoin-induced interstitial pulmonary fibrosis. Presentation and outcome
39. Pulmonary reaction to nitrofurantoin
40. Nitrofurantoin
41. Chemotherapy-associated pulmonary toxic reactions during treatment for breast cancer
42. Relationship of toxic reactions in gold therapy to improvement in rheumatoid arthritis
43. Adverse reaction to d-penicillamine after gold toxicity
44. Prior gold therapy does not influence the adverse effects of d-penicillamine in rheumatoid arthritis
45. Toxicity of d-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with nephrotic syndrome
46. Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold?
47. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy
48. d-penicillamine in the treatment of rheumatoid arthritis
49. Relationship of gold and penicillamine therapy to diffuse interstitial lung disease
50. Pneumonitis caused by gold salt therapy: Evidence for the role of cellmediated immunity in its pathogenesis
51. Progressive airway obliteration in adults and its association with rheumatoid disease